Mohammad Khalil: Evaluating DAPT Duration after Percutaneous Coronary Intervention
Mohammad Khalil, Bachelor of Medicine at Royal College of Surgeons in Ireland (RCSI), shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cureus Journal of Medical Science, adding:
“I am pleased to share the publication of my latest research article in Cureus Journal of Medical Science:
Short- Versus Standard-Duration Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
This publication marks my first as the lead (first) author, representing a significant milestone in my academic and research journey.
In this systematic review and meta-analysis of 23,586 patients across seven randomized controlled trials, we evaluated the safety and efficacy of abbreviated dual antiplatelet therapy following PCI in patients with acute coronary syndrome.
Our findings demonstrate that shorter-duration DAPT significantly reduces major bleeding without increasing overall major adverse cardiovascular events, while highlighting the importance of selecting an appropriate P2Y12 inhibitor for maintaining ischemic safety.”
Title: Short- Versus Standard-Duration Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Authors: Mohammad Khalil, Yahia Khalil
Stay updated 0n all scientific advances with Hemostasis Today.
-
Jun 30, 2026, 03:06Salvatore Brugaletta: Is Twelve Months of DAPT Still Too Long After ACS?
-
Jun 30, 2026, 02:55Edward Lee Carter: How A Landmark Stewardship Shift Reduced Unnecessary Antiplatelet Use Across VISN 8
-
Jun 30, 2026, 02:43Nicolas Gendron: More than a Research Fellowship – Leaving the Wagner Lab
-
Jun 30, 2026, 02:29Wolfgang Miesbach: Can We ‘Pre‑Tame’ the Immune System to Unlock Better AAV8 FVIII Expression?
-
Jun 30, 2026, 02:11Rishdha Roshad: Activated Clotting Time – Adult vs Pediatric
-
Jun 30, 2026, 02:02Julia Castillo González: Role of Cortistatin During the Acute and Subacute Phases of Ischemic Stroke
-
Jun 29, 2026, 23:26Sandy Middleton: The 2026 Stroke Clinical Care Standard Has Arrived with Nursing Leadership at Its Core
-
Jun 29, 2026, 22:14To Continue or Interrupt DOAC Therapy? The Evidence Remains Unclear – RPTH Journal
-
Jun 29, 2026, 20:09Mamta Soni: The Role of Anti-Xa Monitoring in Anticoagulation Management